Evidence map›Paper›PMID 32665350›Full record

ArticleBMJ open2020

Pharmacists' roles in supporting people living with severe and persistent mental illness: a systematic review protocol.

Sarira El-Den, Sara S McMillan, Amanda J Wheeler, Ricki Ng, Helena Roennfeldt, Claire L O'Reilly

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarira El-DenSydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-7500-3351
Sara S McMillanSchool of Pharmacy and Pharmacology, Griffith University, Southport, Queensland, Australia.ORCID 0000-0003-3427-4467
Amanda J WheelerMenzies Health Institute, Griffith University, Nathan, Queensland, Australia.ORCID 0000-0001-9755-674X
Ricki NgSydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-1334-6487
Helena RoennfeldtMenzies Health Institute, Griffith University, Nathan, Queensland, Australia.ORCID 0000-0002-4569-1226
Claire L O'ReillySydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia claire.oreilly@sydney.edu.au.ORCID 0000-0001-6416-8150

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSevere and persistent mental illness (SPMI) can significantly impact a person's social, personal and professional life. Previous studies have demonstrated pharmacists' roles in mental healthcare; however, limited studies to date have focused on pharmacists' roles in providing healthcare services, specifically, to people living with SPMI. The aim of this systematic review is to explore the pharmacists' roles in providing support to people living with SPMI. METHODS AND ANALYSIS: A systematic search will be conducted in Medline, Embase (Ovid), PsycINFO, CINAHL, Web of Science, Scopus, Cochrane Library, International Pharmaceutical Abstracts and ProQuest Dissertations and Theses to identify potentially relevant primary research for inclusion. This will be guided by the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols checklist for systematic reviews. All primary research publications regardless of study design exploring or reporting on pharmacists' involvement in supporting people living with SPMI will be considered for inclusion. A tabular summary will be completed using data extracted from each included publication. Data synthesis and quality assessment methods will be chosen based on included study designs. ETHICS AND DISSEMINATION: The results will be published in a peer-reviewed journal and used to inform the development of a pharmacist-specific training package to support people living with SPMI. PROSPERO REGISTRATION NUMBER: CRD42020170711.

Indexed as

Mental DisordersPharmacistsDelivery of Health CareHumansMeta-Analysis as TopicSystematic Reviews as Topicmedical education & trainingquality in health careschizophrenia & psychotic disorders

Identifiers

PMID32665350
PMCPMC7359051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.